Symbols / GLTO $28.69 -0.76% Galecto Inc

No company description available for this symbol.

Price estimates from analyst targets and simple models.

• Assessing Galecto (GLTO) Valuation After Sharp Short-Term Share Price Momentum - Yahoo Finance Sun, 15 Feb 2026 08
• Cancer drug developer Galecto plans stock sale to fund antibody trials - Stock Titan ue, 10 Feb 2026 08
• GLTO, MOVE: two penny stocks quadrupled today – but should you buy? - TradingView Mon, 10 Nov 2025 08
• GLTO Stock Rises A Whopping 632% Pre-Market, But Retail Investors Remain Cautious - Stocktwits ue, 07 Oct 2025 07
• Why Is Galecto Stock (GLTO) Up 285% Today? - TipRanks Mon, 10 Nov 2025 08
• This Penny Stock Just Quadrupled. Should You Buy It Now? - Barchart.com Mon, 10 Nov 2025 08
• Galecto stock soars after Damora Therapeutics acquisition - Investing.com Mon, 10 Nov 2025 08
• This Penny Stock Just Jumped 750%. Can It Retain These Gains for the Long Term? - Yahoo Finance ue, 07 Oct 2025 07
• Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Fundi - Benzinga Mon, 10 Nov 2025 08
• Biotech Galecto gives new hires options for 153,700 shares - Stock Titan Wed, 04 Mar 2026 08
• Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN) - The Globe and Mail ue, 03 Feb 2026 08
• Could GLTO Become the Next Big Pharma Star?​ - StocksToTrade ue, 23 Sep 2025 07
• Why Is Galecto Stock (GLTO) Up 575% Today? - TipRanks ue, 07 Oct 2025 07
• Damora Therapeutics holds $535M cash to target rare blood cancers - Stock Titan Mon, 09 Mar 2026 07
• Galecto (GLTO) Is Up 15.3% After $316 Million Equity Raise And New Shelf Registration - What's Changed - Yahoo Finance Sun, 15 Feb 2026 08

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).